Idiopathic Pulmonary Fibrosis
Condition
Definition
Idiopathic pulmonary fibrosis (IPF) is a chronic disease of the lungs. It causes inflammation and scarring of lung tissue.
Causes
Idiopathic means the cause is not known.
Something starts uncontrolled inflammation. The inflammation damages tissue and leads to scarring. Over time, the scars surround the thin air sacs in the lungs. They make the sacs thicker and stiffer. Gases like oxygen will have a harder time passing through these sacs. You will have to breathe harder to get enough oxygen. The lungs will worsen until they lose their ability to pass oxygen.
Copyright © 2002 Nucleus Communications, Inc. All rights reserved.

Risk Factors
IPF occurs most often in males and people aged 50 years and older. Other factors that may increase your chance of IPF include:
- Cigarette smoking
- Viral infection
- Frequent exposure to dusts containing wood, metal, silica, bacteria, and animal proteins or to aerosol sprays, gases, and fumes
- Gastroesophageal reflux disease (GERD)
- Other family members with IPF
Symptoms
Symptoms get worse over time. They will make daily tasks difficult. People with IPF gradually start to have some or all of these symptoms:
- Shortness of breath during or after physical activity then later also when resting
- Dry cough
- Gradual weight loss
- Fatigue
- Enlargement of the fingertips, called clubbing, or sometimes the toes
Diagnosis
You will be asked about your symptoms and past health. A physical exam will be done.
Your bodily fluids and tissues may be tested. This can be done with:
- Blood tests
- Lung biopsy—a sample of lung tissue is removed and examined in a lab
Images may be taken of your lungs. This can be done with:
- Chest x-ray
- CT scan
- Bronchoscopy
Your lung function may be tested. This can be done with:
- Pulmonary function tests
- An exercise test
Treatment
There is no known cure. The goal of treatment is to ease symptoms. Options include:
Prevention
There is no proven way to prevent most IPF. Proper protection when working at a high risk job may help.
Medicine
Medicine may help to ease some symptoms. A combination of medicine may be used to:
- Reduce inflammation
- Slow or decrease the immune response
- Slow the progress of scarring
Pirfenidone and nintedanib may help to slow fibrosis. This may slow worsening of lung function
American Lung Association
Coalition for Pulmonary Fibrosis
CANADIAN RESOURCES
Health Canada
The Lung Association
References:
Explore idiopathic pulmonary fibrosis. National Heart, Lung, and Blood Institute website. Available at: https://www.nhlbi.nih.gov/health-topics/idiopathic-pulmonary-fibrosis. Accessed January 17, 2019.
Idiopathic pulmonary fibrosis. American Thoracic Society. Available at: https://www.thoracic.org/patients/patient-resources/resources/idiopathic-pulmonary-fibrosis.pdf. Accessed January 17, 2019.
Idiopathic pulmonary fibrosis. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T114208/Idiopathic-pulmonary-fibrosis . Updated December 4, 2018. Accessed January 17, 2019.
Pulmonary fibrosis. American Lung Association website. Available at: http://www.lung.org/lung-disease/pulmonary-fibrosis. Accessed January 17, 2019.
American Lung Association
Coalition for Pulmonary Fibrosis
CANADIAN RESOURCES
Health Canada
The Lung Association
References:
Explore idiopathic pulmonary fibrosis. National Heart, Lung, and Blood Institute website. Available at: https://www.nhlbi.nih.gov/health-topics/idiopathic-pulmonary-fibrosis. Accessed January 17, 2019.
Idiopathic pulmonary fibrosis. American Thoracic Society. Available at: https://www.thoracic.org/patients/patient-resources/resources/idiopathic-pulmonary-fibrosis.pdf. Accessed January 17, 2019.
Idiopathic pulmonary fibrosis. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T114208/Idiopathic-pulmonary-fibrosis . Updated December 4, 2018. Accessed January 17, 2019.
Pulmonary fibrosis. American Lung Association website. Available at: http://www.lung.org/lung-disease/pulmonary-fibrosis. Accessed January 17, 2019.
Contributors
- EBSCO Medical Review Board
(C) Copyright 2023 EBSCO Information Services
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com.